Cargando…

Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System

IMPORTANCE: Long-term follow-up is needed to evaluate gaps in HIV preexposure prophylaxis (PrEP) care delivery and to identify individuals at risk for falling out of care. OBJECTIVE: To characterize the PrEP continuum of care, including prescription, initiation, discontinuation, and reinitiation, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hojilla, J. Carlo, Hurley, Leo B., Marcus, Julia L., Silverberg, Michael J., Skarbinski, Jacek, Satre, Derek D., Volk, Jonathan E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391097/ https://www.ncbi.nlm.nih.gov/pubmed/34436609 http://dx.doi.org/10.1001/jamanetworkopen.2021.22692

Ejemplares similares

Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US
por: Harrington, Kristin R. V., et al.
Publicado: (2023)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial
por: Wang, Hongyi, et al.
Publicado: (2022)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis
por: McManus, Kathleen A., et al.
Publicado: (2023)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
por: Streed, Carl G., et al.
Publicado: (2022)

Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care
por: Krakower, Douglas, et al.
Publicado: (2019)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Women Trust Their OBGYNs to Provide Preexposure Prophylaxis: An Opportunity for HIV Prevention
por: Danvers, Antoinette A., et al.
Publicado: (2022)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
por: Huang, Ya-lin A., et al.
Publicado: (2018)

Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis
por: Ong, Jason J., et al.
Publicado: (2019)

32. Influenza Vaccination Prevalence Among Adults with and without HIV by Race, Age, and Sex
por: Levine-Hall, Tory, et al.
Publicado: (2020)

Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men
por: McManus, Hamish, et al.
Publicado: (2020)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020
por: Tanner, Mary R., et al.
Publicado: (2020)

Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM
por: Estcourt, Claudia, et al.
Publicado: (2021)

Oral conditions and salivary analysis in HIV-uninfected subjects using preexposure prophylaxis
por: Macedo, Nayara, et al.
Publicado: (2022)

No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
por: Marcus, Julia L., et al.
Publicado: (2013)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

A Preliminary Study of the Attitudes and Barriers of Family Physicians to Prescribing HIV Preexposure Prophylaxis
por: Ojile, Nicholas, et al.
Publicado: (2017)

In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
por: Mitchell, Kate M., et al.
Publicado: (2018)

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men
por: Hoenigl, Martin, et al.
Publicado: (2018)

Implementation of HIV Preexposure Prophylaxis in a Homeless Primary Care Setting at the Veterans Affairs
por: Gregg, Elizabeth, et al.
Publicado: (2020)

961. Prevalence and Macrolide Resistance of Mycoplasma genitalium After Initiation of HIV Preexposure Prophylaxis
por: Van Praet, Jens, et al.
Publicado: (2019)

Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis
por: Shaik, Jafar Sadik, et al.
Publicado: (2021)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial
por: Solomon, Marc M., et al.
Publicado: (2014)

Comparative Effectiveness of Interventions to Improve the HIV Continuum of Care and HIV Preexposure Prophylaxis in Kenya: A Model-Based Analysis
por: Luong Nguyen, Liem B, et al.
Publicado: (2020)

Increased HIV Transmissions With Reduced Insurance Coverage for HIV Preexposure Prophylaxis: Potential Consequences of Braidwood Management v. Becerra
por: Paltiel, A David, et al.
Publicado: (2023)

HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons — United States, 2019
por: Rao, Shubha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gs1j33ej1lguu7mi1c22m4ffbp